INO 10-Q: SEC filing

INOVIO Pharmaceuticals

Filed with the SEC on · accession 0001055726-26-000029

INO filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -4.0% by the first close after the filing.

Summary of the filing

INOVIO Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing subsequent equity financings, including a November 2026 common stock offering and prior warrant/stock issuances.

Key details

FilerINOVIO Pharmaceuticals, Inc.

How INO stock reacted

Close before

$1.51

Nov 9, 2026

First close after

-3.97%

$1.45

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INO?

Click here

Frequently asked questions

What did INO file with the SEC on Nov 10, 2026?

INO filed a 10-Q (SEC filing). INOVIO Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing subsequent equity financings, including a November 2026 common stock offering and prior warrant/stock issuances.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did INO stock react to this filing?

INO closed at $1.51 before the filing and $1.45 on Nov 10, 2026 (-3.97%).

Other INO SEC filings

Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days